Martin Bossart,Ralf Elvert,Andreas Evers,Torsten Haack,Siegfried Stengelin,Michael Wagner,Katrin Lorenz
申请号:
US14679777
公开号:
US09771406B2
申请日:
2015.04.06
申请国别(地区):
US
年份:
2017
代理人:
摘要:
The present invention relates to dual GLP-1/glucagon receptor agonists or optionally trigonal GLP-1/glucagon/GIP receptor agonists and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as for reduction of excess food intake.